Quantum Cyber Raises $15M from Warrant Exercises, Becomes Debt-Free
QUCY has more than doubled off its 52-week low of $0.3.
Summary
Quantum Cyber N.V. secured over $15 million from warrant exercises, eliminating all debt and providing capital for its strategic pivot into autonomous defense technology.
Key Events · Financing and Capital Events · QUCY
-
$15 Million Capital Infusion
The company received over $15 million in gross proceeds from the full exercise of all outstanding warrants.
-
Debt-Free Capital Structure
All outstanding debt obligations have been satisfied and extinguished, leaving Quantum Cyber with a debt-free balance sheet.
-
Funding Strategic Growth
Proceeds will fund R&D expansion, commercialization team build-out, and strategic acquisitions for its autonomous defense platform.
-
Updated Share Count
Following the warrant exercises, 22,767,254 ordinary shares are now issued and outstanding.
Analysis · QUCY · Life Sciences
Quantum Cyber N.V. has significantly strengthened its financial position by receiving over $15 million from the full exercise of outstanding warrants. This substantial capital infusion, representing nearly 30% of its market capitalization, has allowed the company to retire all outstanding debt, resulting in a debt-free capital structure. The proceeds are earmarked for expanding research and development, building out the commercialization team, and funding strategic acquisitions in its new autonomous defense platform business. This provides crucial runway for the company's strategic pivot into AI-powered drone warfare and counter-UAS technologies, which was previously announced.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QUCY was trading at $3.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $50.9M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.